A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This trial is conducted in Europe. The aim of this trial is to investigate the pharmacokinetic (the rate at which the body eliminates the trial drug) and pharmacodynamic (the effect of the trial drug on the body) profiles of NN1218 in comparison with insulin aspart.
Epistemonikos ID: c1f3304c1e49d431babd2e26383486a0be29e325
First added on: May 06, 2024